logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Anjoy Foods (02648.HK) Q1-Q3 net profit attributable to parent company 1.142 billion yuan, up 20.27% year on year.

date
28/10/2026
Zhitong Finance APP News, Anjoy Foods (02648.HK) released its results for the first three quarters of 2026, with operating revenue of RMB 13.461 billion, up 18.38% year on year; net profit attributable to shareholders of the listed company of RMB 1.142 billion, up 20.27% year on year; and basic earnings per share of RMB 3.44.
Latest
2 m ago
Saixiang Technology (002337.SZ) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 37.7256 million, down 24.07% year on year.
3 m ago
China Ruilin (603257.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 107 million yuan, a year-on-year increase of 20.71%.
3 m ago
Xintai Medical (02291.HK) repurchased 1,000 shares on October 28 for HKD 15,000.
4 m ago
Xinning Logistics (300013.SZ) released its performance for the first three quarters, with net profit attributable to the parent company of 37.1103 million yuan, a year-on-year increase of 833.36%.
5 m ago
Biogen (BIIB.US) Q3 results beat expectations, with strong sales of rare disease drugs.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.